Maryanne Demasi, reports

Maryanne Demasi, reports

Share this post

Maryanne Demasi, reports
Maryanne Demasi, reports
DCIS: should we stop calling it "breast cancer"?
Copy link
Facebook
Email
Notes
More

DCIS: should we stop calling it "breast cancer"?

Renewed calls to minimise the overdiagnosis and unnecessary treatment of breast abnormalities

Maryanne Demasi, PhD's avatar
Maryanne Demasi, PhD
Jan 09, 2025
∙ Paid
167

Share this post

Maryanne Demasi, reports
Maryanne Demasi, reports
DCIS: should we stop calling it "breast cancer"?
Copy link
Facebook
Email
Notes
More
28
24
Share

The debate over how to manage ductal carcinoma in situ (DCIS) has gained momentum following a recent study suggesting that surgery might not be necessary for women diagnosed with the condition.

Often described as "stage zero breast cancer" or "a very early form of breast cancer," DCIS is not actually cancer but rather a cluster of abnormal cells contained within the milk ducts.

Despite its non-cancerous status, the use of terms like “carcinoma” or “cancer” can cause considerable anxiety, prompting many women to choose aggressive treatments such as surgery and radiation—interventions that may not offer any clear benefit to their outcomes.

Mayo Clinic overview of DCIS

Last month, a new randomised trial, published in JAMA once again, challenged the necessity of surgery for DCIS.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Maryanne Demasi
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More